Skip to content
Screener

Solventum SOLV Stock-Based Comp

Stock-Based Comp at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$58M+41.5%
3M logo
3MMMM
$41M-6.8%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
$1.03M-21.2%
Cardinal Health logo
Cardinal HealthCAH
$129M+316%
UnitedHealth Group logo
UnitedHealth GroupUNH
$348M-7.2%
DENTSPLY SIRONA logo
DENTSPLY SIRONAXRAY
$9M0.0%

Other financials

Income statement

See full
Revenue$2.2B+2.2%
Gross profit$1.3B+9.4%
Operating income$181.0M-15.4%
Net income$92.0M+2.2%
EPS (diluted)$0.53+3.9%

Balance sheet

See full
Cash & equivalents$403.0M-18.1%
Total debt$5.8B-25.9%
Total equity$4.8B+31.7%
Total assets$14.2B-5.5%

Cash flow

See full
Operating cash flow$227.0M+34.3%
CapEx$83.0M-24.5%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$15.15B+20.6%
Enterprise value$20.54B+3.3%
P/E10.6×-22.5×
P/S1.8×+0.3×

Profitability

See full
Gross margin54.7%+0.2pp
Operating margin25%+15.7pp
Net margin17.3%+12.7pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34%+22.3pp
Debt / equity1.2×-0.9×
Current ratio-0.2×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Solventum’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:27 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001964738-26-000047
(Millions)Six months ended June 30, 2026Six months ended June 30, 2025
Adjustments to reconcile net income to net cash provided by (used in) operating activities
Depreciation and amortization268251
Pension and postretirement benefits2732
Stock-based compensation expense8983
Deferred income taxes(88)(177)
Changes in assets and liabilities
Accounts receivable(286)(15)
Due from related parties274

Item 1. Financial Statements

FAQ

What is Solventum's stock-based comp?
Solventum (SOLV) reported stock-based comp of $38M in Q2 2026.
How has Solventum's stock-based comp changed year-over-year?
Solventum's stock-based comp increased by 11.8% year-over-year, from $34M to $38M.
What is the long-term trend for Solventum's stock-based comp?
Over 3 years (2022 to 2025), Solventum's stock-based comp has grown at a 63.3% compound annual growth rate (CAGR), from $37M to $161M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about Solventum's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude